Takeo Naito, PhD, joined the McGovern Laboratory/Translational Genomics Group at Cedars Sinai in October 2018. He graduated from University of Yamanashi Graduate School of Medical Science, Japan, in 2009. From 2009 to 2013, Naito worked as a resident. He received his doctorate in 2017 from Tohoku University School of Medicine, Japan. At Tohoku University, Naito conducted translational researches between genetic background of inflammatory bowel disease (IBD) and its clinical phenotype. He identified candidate genes for Paneth cell defect in Japanese Crohn’s disease and decreased bone mineral density in Japanese IBD. His current research interest is in transcriptomics in IBD for developing new therapy target and precision medicine. Naito is also interested in the difference in genetic background of IBD between races.